Search Results - "Gening, Snezhanna"

Relationship Between Serum Cytokine Profile and Circulating Neutrophils Phenotype in Patients with Benign Ovarian Tumors and Ovarian Cancer by Abakumova, Tatyana V., Gening, Snezhanna O., Gening, Tatyana P.

“…Changes in the cytokine microenvironment determine the anti- (N1) and pro-tumor (N2) activity of neutrophils (Nph), which has been shown in multiple in vitro…”
Get full text

The Detection of Stem-Like Circulating Tumor Cells Could Increase the Clinical Applicability of Liquid Biopsy in Ovarian Cancer by Gening, Snezhanna O., Abakumova, Tatyana V., Gafurbaeva, Dina U., Rizvanov, Albert A., Antoneeva, Inna I., Miftakhova, Regina R., Peskov, Andrey B., Gening, Tatyana P.

“…Stem properties allow circulating tumor cells (CTCs) to survive in the bloodstream and initiate cancer progression. We aimed to assess the numbers of stem-like…”
Get full text

Cytokine Status of Serum in Ovarian Cancer Patients with Different Tumor Neoadjuvant Chemotherapy Response by Antoneeva, Inna I, Abakumova, Tatyana V, Dolgova, Dinara R, Gening, Tatyana P, Pirmamedova, Sabina S, Myasnikova, Dinara F, Gening, Snezhanna O

“…Polychemotherapy in ovarian cancer (OC) is the second major component of treatment. However, treatment with cytostatics is stopped in 25% of cases because of…”
Get more information

Effects of CAP-regimen Chemotherapy on Blood Redox Status in Patients with Ovarian Cancer by Antoneeva, Inna I, Dolgova, Dinara R, Gening, Tatyana P, Abakumova, Tatyana V, Gening, Snezhanna O, Pirmamedova, Sabina S, Fomina, Anastasia V, Mikheenko, Alla A

“…Ovarian cancer (OC) is the most lethal of gynecologic tumors because women generally present with advanced stage disease. Platinum-based chemotherapy play a…”
Get more information

The Plasticity of Circulating Tumor Cells in Ovarian Cancer During Platinum-containing Chemotherapy by Gening, Snezhanna Olegovna, Dolgova, Dinara Rishatovna, Abakumova, Tatyana Vladimirovna, Antoneeva, Inna Ivanovna, Gening, Tatyana Petrovna

“…Circulating Tumor Cells (CTCs) are a potential source of metastases and relapses. The data on molecular characteristics of Ovarian Cancer (OC) CTCs are…”
Get more information

IL-17A and CCL2 in blood serum and circulating neutrophils in patients with ovarian tumors by Gening, Snezhanna, Abakumova, Tatyana, Gening, Tatyana

“…Abstract only e17536 Background: During the ovarian carcinogenesis, circulating neutrophils (Nph) phenotype switches to the pro-tumor, with an increase in the…”
Get full text

Stem-like markers in the circulating tumor cells assessment in ovarian cancer by Gening, Snezhanna, Abakumova, Tatyana, Antoneeva, Inna, Gening, Tatyana

“…Abstract only e17542 Background: Circulating tumor cells (CTCs) are a potential source of dissemination and relapse in ovarian cancer (OC). Stem cell…”
Get full text

Afebrile chemotherapy-induced neutropenia: an international survey spots oncologists’ routine clinical practice versus the standard of care and the impact of COVID-19 by Saad, Ereny Samwel Poles, Oualla, Karima, Talibova, Narmin, Gening, Snezhanna, YousefYousef, Shady Gayed

“…Introduction Afebrile chemotherapy-induced neutropenia represents a frequent clinical situation where chemotherapy protocol, patient’s comorbidities, and…”
Get full text

Parameters of the glutathione system and thioredoxin in blood plasma and ascites and GSTP1 Ile105Val gene polymorphism as factors of resistance to platinum-containing chemotherapy in ovarian cancer patients by Dolgova, D. R., Gening, T. R., Abakumova, T. V., Gening, S. O., Antoneeva, I. I., Fedotova, A. Yu

“…Background. Chemotherapy is one of the main types of treatment in ovarian cancer. Standard first-line treatment includes platinum drugs. Every fifth patient…”
Get full text